Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 218

1.

Is there evidence of birth control in late Imperial China?

Wolf AP.

Popul Dev Rev. 2001;27(1):133-54. No abstract available.

PMID:
19097324
3.

Mechanism of nitrogen-13-labeled ammonia formation in a cryogenic water target.

Firouzbakht ML, Schlyer DJ, Wolf AP, Fowler JS.

Nucl Med Biol. 1999 May;26(4):437-41.

PMID:
10382848
4.

Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition.

Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Wolf AP, Warner D, Cilento R, Zezulkova I.

J Addict Dis. 1998;17(1):23-34.

PMID:
9549600
5.

Yield measurements for the 11B(p,n)11C and the 10B(d,n)11C nuclear reactions.

Firouzbakht ML, Schlyer DJ, Wolf AP.

Nucl Med Biol. 1998 Feb;25(2):161-4.

PMID:
9468031
6.

Long-term stability of neurotransmitter activity investigated with 11C-raclopride PET.

Schlösser R, Brodie JD, Dewey SL, Alexoff D, Wang GJ, Fowler JS, Volkow N, Logan J, Wolf AP.

Synapse. 1998 Jan;28(1):66-70.

PMID:
9414019
7.

Carbon-11 labelled ketamine-synthesis, distribution in mice and PET studies in baboons.

Shiue CY, Vallabhahosula S, Wolf AP, Dewey SL, Fowler JS, Schlyer DJ, Arnett CD, Zhou YG.

Nucl Med Biol. 1997 Feb;24(2):145-50.

PMID:
9089707
8.

Brain monoamine oxidase A inhibition in cigarette smokers.

Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor RR, Schlyer DJ, Zezulkova I, Wolf AP.

Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14065-9.

9.

Glucose metabolic changes in nontumoral brain tissue of patients with brain tumor following radiotherapy: a preliminary study.

Wang GJ, Volkow ND, Lau YH, Fowler JS, Meek AG, Park TL, Wong C, Roque CT, Adler AJ, Wolf AP.

J Comput Assist Tomogr. 1996 Sep-Oct;20(5):709-14.

PMID:
8797898
10.

Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol.

Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, MacGregor RR, Schlyer DJ, Hitzemann R, Wolf AP.

Psychiatry Res. 1996 May 31;67(1):11-6.

PMID:
8797238
11.

The prevalence of agitation and brain injury in skilled nursing facilities: a survey.

Wolf AP, Gleckman AD, Cifu DX, Ginsburg PC.

Brain Inj. 1996 Apr;10(4):241-5.

PMID:
9044689
12.

Opioid receptor imaging and displacement studies with [6-O-[11C] methyl]buprenorphine in baboon brain.

Galynker I, Schlyer DJ, Dewey SL, Fowler JS, Logan J, Gatley SJ, MacGregor RR, Ferrieri RA, Holland MJ, Brodie J, Simon E, Wolf AP.

Nucl Med Biol. 1996 Apr;23(3):325-31.

PMID:
8782244
13.

Time-dependent effects of a haloperidol challenge on energy metabolism in the normal human brain.

Bartlett EJ, Brodie JD, Simkowitz P, Dewey SL, Rusinek H, Volkow ND, Wolf AP, Smith G, Wolkin A, Cancro R.

Psychiatry Res. 1996 Mar 29;60(2-3):91-9.

PMID:
8723299
14.

Cocaine uptake is decreased in the brain of detoxified cocaine abusers.

Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemannn R, Gatley SJ, MacGregor RR, Wolf AP.

Neuropsychopharmacology. 1996 Mar;14(3):159-68.

15.

Blunted change in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms.

Wolkin A, Sanfilipo M, Duncan E, Angrist B, Wolf AP, Cooper TB, Brodie JD, Laska E, Rotrosen JP.

Am J Psychiatry. 1996 Mar;153(3):346-54.

PMID:
8610821
16.

Inhibition of monoamine oxidase B in the brains of smokers.

Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R.

Nature. 1996 Feb 22;379(6567):733-6.

PMID:
8602220
17.

[18F]haloperidol binding in baboon brain in vivo.

Yousef KA, Fowler JS, Volkow ND, Dewey SL, Shea C, Schlyer DJ, Gatley SJ, Logan J, Wolf AP.

Nucl Med Biol. 1996 Jan;23(1):47-52.

PMID:
9004914
18.

Plasma input function determination for PET using a commercial laboratory robot.

Alexoff DL, Shea C, Fowler JS, King P, Gatley SJ, Schlyer DJ, Wolf AP.

Nucl Med Biol. 1995 Oct;22(7):893-904.

PMID:
8547887
19.
20.

Depression of thalamic metabolism by lorazepam is associated with sleepiness.

Volkow ND, Wang GJ, Hitzemann R, Fowler JS, Pappas N, Lowrimore P, Burr G, Pascani K, Overall J, Wolf AP.

Neuropsychopharmacology. 1995 Apr;12(2):123-32.

21.

Regional brain metabolic response to lorazepam in subjects at risk for alcoholism.

Volkow ND, Wang GJ, Begleiter H, Hitzemann R, Pappas N, Burr G, Pascani K, Wong C, Fowler JS, Wolf AP.

Alcohol Clin Exp Res. 1995 Apr;19(2):510-6.

PMID:
7625590
22.

Serotonin 5-HT2 receptor availability in chronic cocaine abusers.

Wang GJ, Volkow ND, Logan J, Fowler JS, Schlyer D, MacGregor RR, Hitzemann RJ, Gjedde A, Wolf AP.

Life Sci. 1995 Mar 10;56(16):PL299-303.

PMID:
8614247
23.

Positron emission tomography. Biomedical research and clinical application.

Wolf AP, Fowler JS.

Neuroimaging Clin N Am. 1995 Feb;5(1):87-101. Review.

PMID:
7743087
24.

Haloperidol blocks the uptake of [18F]N-methylspiroperidol by extrastriatal dopamine receptors in schizophrenic patients.

Yousef KA, Volkow ND, Schlyer DJ, Fowler JS, Wolf AP, Wang GJ, Smith MR, Brodie JD, Warner D.

Synapse. 1995 Jan;19(1):14-7.

PMID:
7709339
25.

Comparison of two pet radioligands for imaging extrastriatal dopamine transporters in human brain.

Wang GJ, Volkow ND, Fowler JS, Ding YS, Logan J, Gatley SJ, MacGregor RR, Wolf AP.

Life Sci. 1995;57(14):PL187-91.

PMID:
7564877
26.

Evaluation of age-related changes in serotonin 5-HT2 and dopamine D2 receptor availability in healthy human subjects.

Wang GJ, Volkow ND, Logan J, Fowler JS, Schlyer D, MacGregor RR, Hitzemann RJ, Gur RC, Wolf AP.

Life Sci. 1995;56(14):PL249-53.

PMID:
7475891
27.

Remote processing, delivery and injection of H2[15O] produced from a N2/H2 gas target using a simple and compact apparatus.

Ferrieri RA, Alexoff DL, Schlyer DJ, Wolf AP.

Appl Radiat Isot. 1994 Dec;45(12):1149-54.

PMID:
7894394
28.

Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawal.

Fowler JS, Volkow ND, Logan J, Wang GJ, MacGregor RR, Schyler D, Wolf AP, Pappas N, Alexoff D, Shea C, et al.

Synapse. 1994 Oct;18(2):86-93.

PMID:
7839316
29.

Pharmacokinetics and in vivo specificity of [11C]dl-threo-methylphenidate for the presynaptic dopaminergic neuron.

Ding YS, Fowler JS, Volkow ND, Gatley SJ, Logan J, Dewey SL, Alexoff D, Fazzini E, Wolf AP.

Synapse. 1994 Oct;18(2):152-60.

PMID:
7839313
30.

Intersubject variability of brain glucose metabolic measurements in young normal males.

Wang GJ, Volkow ND, Wolf AP, Brodie JD, Hitzemann RJ.

J Nucl Med. 1994 Sep;35(9):1457-66.

31.

Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology.

Wolkin A, Sanfilipo M, Angrist B, Duncan E, Wieland S, Wolf AP, Brodie JD, Cooper TB, Laska E, Rotrosen JP.

Biol Psychiatry. 1994 Sep 1;36(5):317-25.

PMID:
7993958
32.

Decreased dopamine transporters with age in health human subjects.

Volkow ND, Fowler JS, Wang GJ, Logan J, Schlyer D, MacGregor R, Hitzemann R, Wolf AP.

Ann Neurol. 1994 Aug;36(2):237-9.

PMID:
8053661
33.

Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects.

Bartlett EJ, Brodie JD, Simkowitz P, Dewey SL, Rusinek H, Wolf AP, Fowler JS, Volkow ND, Smith G, Wolkin A, et al.

Am J Psychiatry. 1994 May;151(5):681-6.

PMID:
8166309
34.
35.

Recovery of brain glucose metabolism in detoxified alcoholics.

Volkow ND, Wang GJ, Hitzemann R, Fowler JS, Overall JE, Burr G, Wolf AP.

Am J Psychiatry. 1994 Feb;151(2):178-83.

PMID:
8296885
36.

Positron emission tomography study of human prostatic adenocarcinoma using carbon-11 putrescine.

Wang GJ, Volkow ND, Wolf AP, Madajewicz S, Fowler JS, Schlyer DJ, MacGregor RR.

Nucl Med Biol. 1994 Jan;21(1):77-82.

PMID:
9234267
37.

Diminished cerebral metabolic response to motor stimulation in schizophrenics: a PET study.

Guenther W, Brodie JD, Bartlett EJ, Dewey SL, Henn FA, Volkow ND, Alper K, Wolkin A, Cancro R, Wolf AP.

Eur Arch Psychiatry Clin Neurosci. 1994;244(3):115-25.

PMID:
7803524
38.

Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects.

Dewey SL, Smith GS, Logan J, Brodie JD, Simkowitz P, MacGregor RR, Fowler JS, Volkow ND, Wolf AP.

Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11816-20.

39.

Impurities in the [18O]water target and their effect on the yield of an aromatic displacement reaction with [18F]fluoride.

Schlyer DJ, Firouzbakht ML, Wolf AP.

Appl Radiat Isot. 1993 Dec;44(12):1459-65.

PMID:
8257964
40.

Comparison of two PET radioligands for imaging extrastriatal dopamine receptors in the human brain.

Wang GJ, Volkow ND, Fowler JS, Wolf AP, MacGregor RR, Shea CE, Schlyer DJ, Hitzemann RJ.

Synapse. 1993 Nov;15(3):246-9. No abstract available.

PMID:
8278901
41.

Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: the degree and reversibility of human brain MAO B inhibition by Ro 19 6327.

Fowler JS, Volkow ND, Logan J, Schlyer DJ, MacGregor RR, Wang GJ, Wolf AP, Pappas N, Alexoff D, Shea C, et al.

Neurology. 1993 Oct;43(10):1984-92.

PMID:
8413955
42.

Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers.

Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP.

Synapse. 1993 Jun;14(2):169-77.

PMID:
8101394
43.

Direct analysis of Kryptofix 2.2.2 in 18FDG by gas chromatography using a nitrogen-selective detector.

Ferrieri RA, Schlyer DJ, Alexoff DL, Fowler JS, Wolf AP.

Nucl Med Biol. 1993 Apr;20(3):367-9. No abstract available.

PMID:
8485498
44.

Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels.

Dewey SL, Smith GS, Logan J, Brodie JD, Fowler JS, Wolf AP.

Synapse. 1993 Apr;13(4):350-6.

PMID:
8480281
45.

Rapid radiochemical and chemical quality control of [11C]putrescine.

Gatley SJ, Ferrieri RA, Fowler JS, MacGregor RR, Wolf AP.

Appl Radiat Isot. 1993 Apr;44(4):765-7.

PMID:
8472030
46.

Comparison of high specific activity (-) and (+)-6-[18F]fluoronorepinephrine and 6-[18F]fluorodopamine in baboons: heart uptake, metabolism and the effect of desipramine.

Ding YS, Fowler JS, Dewey SL, Logan J, Schlyer DJ, Gatley SJ, Volkow ND, King PT, Wolf AP.

J Nucl Med. 1993 Apr;34(4):619-29.

47.

Decreased cerebral response to inhibitory neurotransmission in alcoholics.

Volkow ND, Wang GJ, Hitzemann R, Fowler JS, Wolf AP, Pappas N, Biegon A, Dewey SL.

Am J Psychiatry. 1993 Mar;150(3):417-22.

PMID:
8382010
48.

Synthesis and PET studies of fluorine-18-BMY 14802: a potential antipsychotic drug.

Ding YS, Fowler JS, Dewey SL, Wolf AP, Logan J, Gatley SJ, Volkow ND, Shea C, Taylor DP.

J Nucl Med. 1993 Feb;34(2):246-54.

49.

Negative symptoms and hypofrontality in chronic schizophrenia.

Wolkin A, Sanfilipo M, Wolf AP, Angrist B, Brodie JD, Rotrosen J.

Arch Gen Psychiatry. 1992 Dec;49(12):959-65.

PMID:
1360200
50.

A universal water target loading system with direct in-target liquid level sensing.

Ferrieri RA, Alexoff DL, Schlyer DJ, Wolf AP.

Int J Rad Appl Instrum A. 1992 Dec;43(12):1485-91.

PMID:
1334955

Supplemental Content

Support Center